CN110706199A - Z spectrum fitting method based on pseudo-Poincke decoupling type and CEST MRI quantification method - Google Patents

Z spectrum fitting method based on pseudo-Poincke decoupling type and CEST MRI quantification method Download PDF

Info

Publication number
CN110706199A
CN110706199A CN201910808222.9A CN201910808222A CN110706199A CN 110706199 A CN110706199 A CN 110706199A CN 201910808222 A CN201910808222 A CN 201910808222A CN 110706199 A CN110706199 A CN 110706199A
Authority
CN
China
Prior art keywords
fitting
cest
spectrum
pseudo
pvp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910808222.9A
Other languages
Chinese (zh)
Other versions
CN110706199B (en
Inventor
宋小磊
张利红
别崇雪
陈雁蓉
赵映程
梁宇华
贺小伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northwest University
Original Assignee
Northwest University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwest University filed Critical Northwest University
Priority to CN201910808222.9A priority Critical patent/CN110706199B/en
Publication of CN110706199A publication Critical patent/CN110706199A/en
Application granted granted Critical
Publication of CN110706199B publication Critical patent/CN110706199B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00Image analysis
    • G06T7/0002Inspection of images, e.g. flaw detection
    • G06T7/0012Biomedical image inspection
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T17/00Three dimensional [3D] modelling, e.g. data description of 3D objects
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T5/00Image enhancement or restoration
    • G06T5/50Image enhancement or restoration using two or more images, e.g. averaging or subtraction
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T5/00Image enhancement or restoration
    • G06T5/70Denoising; Smoothing
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/10Image acquisition modality
    • G06T2207/10072Tomographic images
    • G06T2207/10088Magnetic resonance imaging [MRI]

Landscapes

  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Geometry (AREA)
  • Software Systems (AREA)
  • Computer Graphics (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Quality & Reliability (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)

Abstract

The invention belongs to the field of CEST MRI, and discloses a Z spectrum fitting method based on a pseudo-Fockel cast-off line type and a CEST MRI quantification method. For any pixel in a CEST MRI image, a pseudo-Pocketsingle line type (PVP) is used for replacing Lorentz as a fitting function, so that the fitting method is suitable for fitting under the conditions of higher saturation power and higher magnetization transfer content in tissues, and the fitting robustness is improved; secondly, different B is calculated according to the five-pool Bloch simulation1‑satThe positive and negative sides of the Z spectrum are respectively optimized and compensated during fitting of the lower Z spectrum, and the positive and negative sides of the Z spectrum acquired by experiment are respectively optimized according to the optimized and compensated coefficient to compensate different B1‑satDirect water saturation in the lower Z spectrumAnd MT contribution; thirdly, considering the asymmetry of MT, the positive side and the negative side of the Z spectrum after optimized compensation are respectively fitted by using a PVP function to form a CEST quantitative contrast diagram, and the method is expected to be used for the quantification of pre-clinical and clinical CEST MRI.

Description

Z spectrum fitting method based on pseudo-Poincke decoupling type and CEST MRI quantification method
Technical Field
The invention belongs to the field of CEST MRI, and particularly relates to a Z spectrum fitting method based on a pseudo-Poincke decoupling type and a CEST MRI quantification method.
Background
MRI stands for magnetic resonance imaging, while CEST imaging is currently a new MRI imaging technique of great interest to indirectly detect low concentrations of metabolites and molecules of exchangeable protons with specific resonance frequencies by detecting changes in water signal caused by chemical exchange with saturated solute protons. Whereas the concentration of these pools of small solutes in biological tissue is usually only in the millimolar range, the cumulative effect of chemical exchange of water with saturated protons enables signal enhancement, with higher sensitivity, by choosing appropriate experimental parameters.
CEST allows the presence of chemical substances to be indirectly detected by reducing water signals, and various chemical substances to be accurately quantified, so that CEST information required by people can be accurately analyzed, and diseases can be accurately diagnosed. To demonstrate certain CEST effects, the Z spectrum is typically generated by acquiring a large amount of water signal intensity as a function of Radio Frequency (RF) saturation frequency shift. To achieve accurate and reliable CEST quantization, the impact of competing processes must be eliminated. Direct water saturation signal (DS), semi-solid magnetization transfer effect (MTC) and nuclear austenite effect (NOE) are several major competing effects. Meanwhile, the static magnetic field B0, saturation power (B) is applied due to these competing effects1-sat) And other experimental parameters, rendering CEST a complex technique. One of the most commonly used quantification methods for CEST MRI is the magnetic transfer rate asymmetry (MTRasym) analysis, MTRasym is simple and easy to calculate and has been shown to correlate with the staging of tumors by APT. However, MTRasym is susceptible to several disturbances including B0 field inhomogeneity, DS and MT, and more importantly MTRasym does not distinguish the NOE effect of the upper field well from the CEST contrast.
Z spectrum fitting is an important method of distinguishing the different contributions of various sources in the Z spectrum. Theoretically, the enhancement of CEST signals in the Z spectrum depends on the size of the pool, the exchange law and the relaxation time, as evidenced by the Bloch-McConnell equation. The quantification method of the least square method Z spectrum fitting is used for solving the problems of MT, DS, saturation overflow effect and NOE effect of a plurality of pools, and a Z spectrum fitting method based on a Bloch-McConnell equation is common, but the method is complex in calculation and has strong dependence on the initial value and the boundary of a fitting parameter.
Furthermore, CEST quantification is performed on the basis of a Z spectrum fit, and depending on the shape of the Z spectrum, some other quantification methods have been proposed, including a multi-cell Lorentzian fit and Lorentzian Difference (LD). The multi-cell lorentzian fit is to set the amplitudes of the target CEST signal and NOE to 0 and to fit a lorentzian shape to where each dip in the Z spectrum. However, on the one hand, the multicell lorentz fitting requires intensive data acquisition of the Z spectra, which is time consuming to compare; on the other hand, the multi-cell Lorentzian fitting requires various fitting parameters and is sensitive to the comparison of the signal-to-noise ratio of the Z spectrum. The LD method uses the lorentz type as a reference to describe DS, followed by the difference between the fitted signal and the Z spectrum to quantify the CEST and NOE effects. LD is a relatively simple and robust quantization method, especially at lower B1-satIn cases (. ltoreq.1. mu.T at9.4Tesla), have been shown to be effective in stroke patients. However, LD analysis overestimates CEST and NOE effects. In particular, relatively high saturation powers (B) are required for rapidly exchanging substances1-sat) And stronger Magnetization Transfer (MT) in tissue, the Z spectrum is more gaussian than lorentz, making quantification of LD unreliable.
At present, a simple, robust and accurate quantification method does not exist in CEST MRI research. Therefore, quantification has been a major aspect of CEST MRI studies.
Disclosure of Invention
The invention aims to provide a Z spectrum fitting method based on a pseudo-Pocker offline type and a CEST MRI quantification method, which are used for solving the problem that a simple, robust and accurate quantification method is lacked in CEST MRI research in the prior art.
In order to realize the task, the invention adopts the following technical scheme:
a Z spectrum fitting method based on a pseudo-Poincke cast-off line type comprises the following steps:
step a: obtaining Z spectrum data, respectively utilizing Gaussian function G (delta omega) and Lorentz function L (delta omega) to perform pre-fitting on the Z spectrum data, and respectively obtaining Gaussian pre-fitting result ZGuassAnd Lorentz pre-fitting results ZLoren
Step b: according to ZGuassAnd ZLorenObtaining a Lorentz proportionality coefficient alpha;
step c: establishing a pseudo-Poinck off-line model of a formula I by using the Lorentz proportionality coefficient alpha obtained in the step b, and fitting Z spectrum data according to the pseudo-Poinck off-line model to obtain a Z spectrum fitting result Zpvp
V (delta omega) ≈ alpha x L (delta omega) + (1-alpha) G (delta omega) formula I
Where V (Δ ω) represents a pseudo-fox offline model.
Further, step b comprises the following sub-steps:
step b 1: according to ZGuassAnd ZLorenCalculating the width gamma of the Gaussian half-maximumGAnd half maximum width of lorentz ΓL
Step b 2: calculating the Lorentz proportionality coefficient alpha by adopting a formula II:
Figure BDA0002184283830000031
where Γ represents the half-maximum width of the pseudo-fox trap.
A CEST MRI quantification method, comprising:
the method comprises the steps of obtaining a CEST MRI image of an experimental object, obtaining original Z spectrum data of each pixel point in the CEST MRI image, traversing all the pixel points in the image to obtain CEST quantitative values of all the pixel points, and obtaining a CEST quantitative contrast map according to the CEST quantitative values of all the pixel points, wherein the CEST quantitative value calculation of any pixel point in the CEST MRI image comprises the following steps:
step 1: preprocessing the original Z spectrum data to obtain corrected Z spectrum data Zexp
Step 2: for Z obtained in step 1expUtilizing a Lorentz function to perform pre-fitting to obtain a pre-fitting result ZLoren
And step 3: for Z obtained in step 1expThe positive and negative sides of the Z spectrum are respectively optimized by adopting a formula III and a formula IV to obtain optimized Z spectrum data
Figure BDA0002184283830000041
Figure BDA0002184283830000042
Wherein the content of the first and second substances,
Figure BDA0002184283830000043
optimized Z spectral data representing positive half spectrum, Ratio (delta omega) representing positive half spectrum compensation factor, LposRepresents ZexpRatio ZLorenA low area between the maximum value of the lower-field frequency offset and the maximum value of the lower-field CEST effect ending frequency offset;
wherein the content of the first and second substances,
Figure BDA0002184283830000045
represents the optimized Z spectrum data of the negative half spectrum, Ratio (-delta omega) represents the compensation factor of the negative half spectrum, LnegRepresents ZexpRatio ZLorenA lower area between the maximum value of the upper field frequency offset absolute value and the maximum value of the upper field NOE effect ending frequency offset absolute value;
and 4, step 4: for the product obtained in step 3
Figure BDA0002184283830000046
Blocking, inputting into any pseudo-Pock off-line model of the Z spectrum fitting method based on the pseudo-Pock off-line type for fitting to obtain fitting signal Zpvp_final
And 5: z obtained according to step 4pvp_finalAnd Z obtained in step 1expAnd obtaining a CEST quantization value.
Further, Ratio (Δ ω) is 0.2318 × B1+0.9502,Ratio(-Δω)=0.4219×B1+0.9131 wherein B1The saturation power used in the experiment to acquire the Z spectrum is shown.
Further, step 4 comprises the following substeps:
step 4.1: will be provided with
Figure BDA0002184283830000047
As a first partition, will
Figure BDA0002184283830000048
As a second partition, will
Figure BDA0002184283830000049
As a third segment;
step 4.2: by blocking the first and second blocksInputting the signal into a pseudo-Buddk offline model for fitting, fitting the third block by using an LD method, and obtaining a fitting signal Z according to the fitting results of the three blockspvp_final
Further, in step 4.1, the first fraction is 0.4ppm to 6ppm, the second fraction is-6 ppm to-0.4 ppm, and the third fraction is 0.4ppm to-0.4 ppm.
Further, the CEST quantization value in step 5 includes three calculation methods:
method (a): calculating Z_PVP_finalAnd Z_expThe difference of (c) is used as CEST quantization value;
method (b): calculating Z_expReciprocal of (a) and Z_PVP_finalThe difference of the two inverse numbers of (c) is taken as CEST quantization value;
method (c): calculating Z_PVP_finalAnd Z_expThe area between the difference and the horizontal axis is taken as the CEST quantization value.
Compared with the prior art, the invention has the following technical characteristics:
(1) the invention aims at solving the problem that when compared with a fast-switching CEST substance requiring higher-power irradiation and a higher Magnetization Transfer (MT), a Z spectrum is closer to a Gaussian form instead of Lorentz, and the invention has higher robustness by using PVP to replace the Lorentz as a fitting function.
(2) The invention proposes optimization relying on B1 to better compensate for different B1-satThe contribution of DS and MT in time, reduces the influence of MT effect and noise caused by movement.
(3) The invention considers the asymmetry of MT, and respectively fits the data of the positive side and the negative side of the Z spectrum, and simultaneously, as DS is mainly near 0ppm of the Z spectrum, Lorentz is still used for fitting, thus improving the fitting precision of the invention.
Drawings
Fig. 1 is a flow chart of a CEST MRI quantification method;
FIG. 2 shows compensation coefficients B for the lower and upper fields of MT and DS1-satA relationship diagram of (1);
FIG. 3(a) shows a cell model B of 5 cells1-satFitting results of Z spectra, LD and optimized pseudo-Poincke off-line model at 0.5,1,1.5,2,2.5 and 3 μ T, respectively;
FIG. 3(B) is a view showing a model B of a 6-cell1-satFitting results of Z spectra, LD and optimized pseudo-Poincke off-line model at 0.5,1,1.5,2,2.5 and 3 μ T, respectively;
FIG. 4(a) is an analytical solution for deriving the metric and standard of AREX from optimized pseudo-Pock off-line model fitting under 5-pool model
Figure BDA0002184283830000061
A comparison graph of (A);
FIG. 4(b) is a view showing a model of a 5-cellAnalytical solution for deriving AREX's metric and standard in optimizing fit of pseudo-fox off-line model
Figure BDA0002184283830000062
A comparison graph of (A);
FIG. 5(a) is a view T2 w;
FIG. 5(B) is B1-satMTRasym graph at 2.4 muT
FIG. 5(c) tumor tissue at B1-satA graph of the fitting results for the optimized pseudo-fox off-line model at 0.8 μ T, 1.2 μ T and 2.4 μ T;
FIG. 5(d) Normal tissue at B1-satA graph of the fitting results for the optimized pseudo-fox off-line model at 0.8 μ T, 1.2 μ T and 2.4 μ T;
FIG. 6(a) is a CESTW map;
FIG. 6(b) is a graph of the optimized pseudo-Pock off-line model fit residual frequency tiles plotted with one dimension of Δ ω and all pixels in the marker row;
FIG. 7 is a graph of quantized amplitudes for optimizing fitting of a pseudo-Pockey off-line model.
The embodiments of the invention will be explained and explained in further detail with reference to the figures and the detailed description.
Detailed Description
Example 1
The embodiment discloses a Z spectrum fitting method based on a pseudo-Poincke cast-off line type, which comprises the following steps:
a Z spectrum fitting method based on a pseudo-Poincke cast-off line type comprises the following steps:
step a: obtaining Z spectrum data, respectively utilizing Gaussian function G (delta omega) and Lorentz function L (delta omega) to perform pre-fitting on the Z spectrum data, and respectively obtaining Gaussian pre-fitting result ZGuassAnd Lorentz pre-fitting results ZLoren
Wherein the content of the first and second substances,
Figure BDA0002184283830000071
Δ ω represents the frequency offset difference at the time of pre-fitting,
Figure BDA0002184283830000072
ω1representing the frequency deviation of water resonance during pre-fitting, wherein A represents the amplitude of a proton pool CEST peak during pre-fitting, omega represents the frequency deviation of the proton pool CEST peak during pre-fitting, and sigma represents the line width of the proton pool CEST peak during pre-fitting;
step b: according to ZGuassAnd ZLorenObtaining a Lorentz proportionality coefficient alpha;
step c: establishing a pseudo-Poinck off-line model of a formula I by using the Lorentz proportionality coefficient alpha obtained in the step b, and fitting Z spectrum data according to the pseudo-Poinck off-line model to obtain a Z spectrum fitting result Zpvp
V (delta omega) ≈ alpha x L (delta omega) + (1-alpha) G (delta omega) formula I
Where V (Δ ω) represents a pseudo-fox offline model.
Further, step b comprises the following sub-steps:
step b 1: according to ZGuassAnd ZLorenCalculating the width gamma of the Gaussian half-maximumGAnd half maximum width of lorentz ΓL(ii) a Wherein the content of the first and second substances,sigma represents the line width of a proton pool CEST peak when a Gaussian function is used for fitting; gamma-shapedL2 σ, σ denotes the linewidth of the proton pool CEST peak when fitted with a lorentzian function;
step b 2: calculating the Lorentz proportionality coefficient alpha by adopting a formula II:
wherein Γ represents the half-maximum width of the pseudo-Poincke cast-off line, ΓG 2、ΓG 3、ΓG 4And ΓG 5Respectively representing the width of the Gaussian half- maximum G2, 3, 4 and 5; gamma-shapedL 2、ΓL 3、ΓL 4And ΓL 5Respectively representing half-maximum widths Γ of lorentzLQuadratic, cubic, quartic and quintic ofTo the power.
Example 2
The embodiment discloses a CEST MRI quantification method, which comprises the following steps:
the method comprises the steps of obtaining a CEST MRI image of an experimental object, obtaining original Z spectrum data of each pixel point in the CEST MRI image, traversing all the pixel points in the image to obtain CEST quantitative values of all the pixel points, and obtaining a CEST quantitative contrast map according to the CEST quantitative values of all the pixel points, wherein the CEST quantitative value calculation of any pixel point in the CEST MRI image comprises the following steps:
step 1: preprocessing the original Z spectrum data to obtain corrected Z spectrum data Zexp
Step 2: for Z obtained in step 1expUtilizing a Lorentz function to perform pre-fitting to obtain a pre-fitting result ZLoren
And step 3: for Z obtained in step 1expThe positive and negative sides of the Z spectrum are respectively optimized by adopting a formula III and a formula IV to obtain optimized Z spectrum data
Figure BDA0002184283830000082
Wherein the content of the first and second substances,
Figure BDA0002184283830000084
optimized Z spectral data representing positive half spectrum, Ratio (delta omega) representing positive half spectrum compensation factor, LposRepresents ZexpRatio ZLorenA low area between the maximum value of the lower-field frequency offset and the maximum value of the lower-field CEST effect ending frequency offset; | Δ ω | represents an absolute value of a frequency deviation at the time of fitting
Figure BDA0002184283830000085
Wherein the content of the first and second substances,
Figure BDA0002184283830000086
representing a negative half spectrumThe Ratio (-delta omega) represents a negative half-spectrum compensation factor, LnegRepresents ZexpRatio ZLorenA lower area between the maximum value of the upper field frequency offset absolute value and the maximum value of the upper field NOE effect ending frequency offset absolute value;
and 4, step 4: for the product obtained in step 3Blocking, inputting the blocks into a pseudo-Pocke off-line model of any one of the Z spectrum fitting methods based on the pseudo-Pocke off-line type in the embodiment 1 for fitting to obtain a fitting signal Zpvp_final
And 5: z obtained according to step 4pvp_finalAnd Z obtained in step 1expAnd obtaining a CEST quantization value.
Specifically, Ratio (Δ ω) is 0.2318 × B1+0.9502,Ratio(-Δω)=0.4219×B1+0.9131 wherein B1The saturation power used in the experiment to acquire the Z spectrum is shown.
Specifically, step 4 includes the following substeps:
step 4.1: will be provided withAs a first partition, will
Figure BDA0002184283830000093
As a second partition, will
Figure BDA0002184283830000094
As a third segment;
step 4.2: by blocking the first and second blocks
Figure BDA0002184283830000095
Inputting the signal into a pseudo-Buddk offline model for fitting, fitting the third block by using an LD method, and obtaining a fitting signal Z according to the fitting results of the three blockspvp_final
Specifically, in step 4.1, the first partition is 0.4ppm to 6ppm, the second partition is-6 ppm to-0.4 ppm, and the third partition is 0.4ppm to-0.4 ppm.
Specifically, the CEST quantization value in step 5 includes three calculation methods:
method (a): calculating Z_PVP_finalAnd Z_expThe difference of (c) is used as CEST quantization value;
method (b): calculating Z_expReciprocal of (a) and Z_PVP_finalThe difference of the two inverse numbers of (c) is taken as CEST quantization value;
method (c): calculating Z \uPVP_finalAnd Z_expThe area between the difference and the horizontal axis is taken as the CEST quantization value.
Example 3
The embodiment discloses a CEST MRI quantification method, and the following technical features are disclosed on the basis of the embodiments 1 and 2:
acquiring a CEST MRI image of an experimental object, acquiring original Z spectrum data of each pixel point in the CEST MRI image, traversing all the pixel points in the image to acquire CEST quantitative values of all the pixel points, acquiring a CEST quantitative contrast map from the CEST quantitative values of all the pixel points,
the subject may select a subject, a test animal, and a test sample, for which the raw z-spectrum data is prepared as follows: at9.4Tesla, for B1-satSimulations of bloch equations were performed on 5-and 6-cell models at 0.5,1,1.5,2,2.5, and 3 μ T. Wherein, 5 pond models are: water pool, amide, amine, MT and NOE (3.5ppm, 6 pool models are pool, amide, amine, MT, NOE (1.6ppm) and NOE (3.5ppm), and 6 pool models contain higher MT and NOE components and lower amide and amine components than 5 pool models for the subjects, in vivo MRI experiments were performed on a 11.7Tesla horizontal bore scanner (Bruker Bispec, Germany) using a 23mm diameter transmit-receiver volume coilSAT2500ms) followed by a fast acquisition with relaxation enhancement (RARE) readout. The Z spectrum was collected in the range-6 ppm to 6ppm with an interval of 0.25ppm, B1-sat0.8, 1.2 and 2.4. mu.T, respectively. Other parameters are 5500ms/11ms for TR/TE, 1mm for slice thickness, FOV=1714mm2The matrix size is 96 × 64.
Specifically, in step 3, the maximum value of the lower-field frequency offset is-4 ppm, the maximum value of the lower-field CEST effect ending frequency offset is-6 ppm, the maximum value of the upper-field frequency offset absolute value is 4ppm, the maximum value of the upper-field NOE effect ending frequency offset absolute value is 6ppm, and if the maximum value is a 5-cell exchange model (water, amide, amino, semi-solid Macromolecules (MT) and NOE (3.5ppm)), the original Z spectrum is recorded as: z_5-poolThe result of the fitting using the lorentz function L (Δ ω) is recorded as: z_loren_5pool4ppm to 6ppm are referred to as u _ pos, and 4ppm to-6 ppm are referred to as u _ neg.
The simulated CEST quantitative contrast map was evaluated as follows:
optimization of the pseudofleck-off-line variant AREX, because the relevant parameters are known in advancePVPAnd comparing with an empirical solution to judge the accuracy of the quantification.
Figure BDA0002184283830000111
Is an empirical solution of apparent exchange-dependent relaxation (AREX), independent of T1wNonspecific tissue parameters such as DS and semisolid MT effect, depending only on solute concentration (f)s) Law of exchange of solute with Water (k)) Transverse relaxation rate (R) of solute2s) And irradiation power (ω)1) The formula is as follows:
Figure BDA0002184283830000112
an improvement to the above formula is proposed to make AREX more specific in the presence of MT.
Figure BDA0002184283830000113
R1obs≈(R+fcR1c)/(1+fc)
AREX if pseudo-fox offline modification is optimizedPVPAnd the closer the empirical solution is to illustrating the more accurate the quantization.
The effect of different quantification methods was evaluated with CNR, which is defined as follows:
wherein S is1,2Are the mean values of the two ROIs, respectively, delta1,2Standard deviation of the two ROIs, respectively.
Analysis of Experimental results
The fitting results and in vivo quantification of the present invention are further described in conjunction with fig. 2-7.
FIG. 2 shows the compensation coefficients and B for obtaining positive and negative sides of Z spectrum1-satAnd a flowchart for calculating the relationship. FIG. 3 is B1-satZ spectra at 0.5,1,1.5,2,2.5 and 3 μ T, fitting results and residual spectra for the optimized pseudo-Poincare model. It can be seen that for the Z spectra simulated by the 5-pool model, the peaks of the residual spectra for the optimized pseudo-Pocke de-linear model and the LD both appear at the amide (3.5ppm), amine (2ppm) and NOE (-3.5 ppm); in the 6-cell model, the residual spectrum had a peak of NOE (-1.6ppm) in addition to a peak of the 5-cell model.
We also derived measures of AREX from optimizing the fit of the pseudo-Pock off-line model, and compared the standard analytical solution
Figure BDA0002184283830000121
(FIG. 4). In the comparison of the 5-pool model and the 6-pool model with the analytical solution, it can be seen that all B's for the 5-pool model1-sat,AREXPVPIn amide (3.5ppm) and NOE (-3.5ppm) and analytical solutions
Figure BDA0002184283830000122
Are relatively close. For the 6-pool model with the larger MT component, at lower B1_sat(≤2μT)AREXPVPAnd
Figure BDA0002184283830000123
very close but for B1_sat2.5 μ T and 3 μ T AREXPVPStill underestimate APT。
FIG. 5(a) is T2w plot, marking the tumor region of interest and the contralateral normal tissue region. FIG. 5(B) is B1_satMTR at 2.4. mu.TasymIn this figure, the appearance of high signals at the tumor is seen. FIGS. 5(c) and (d) are each B1_satResults of pseudo-fox cast model fitting were optimized for 0.8 μ T, 1.2 μ T, and 2.4 μ T tumor and normal tissues. It can be seen from the figure that: the drop in Z spectrum is clearly seen at 3.5ppm, 2ppm and-3.5 ppm. A drop (-1.6ppm) was also clearly seen at another point on normal tissue, but not at the tumor. Theoretically, Glu-CEST (3ppm) should be observed at high power, but not due to the broad peak in the Z spectrum. The peaks that optimized the fit of the pseudofudge deshaped model occurred at 3.5ppm, 2ppm, and-2 ppm to-5 ppm for the tumor region of interest and the contralateral region.
To visualize the quantized spectrum of all pixels, we render a frequency-stitched image with one dimension of Δ ω and all pixels in the marker line as shown in fig. 6(a) and fig. 6 (b). The abscissa is between 56 and 66, which is the location of the tumor. For tumors, the optimized pseudo-fox cast model fit values were significantly higher at 3.5ppm and 2ppm than for contralateral normal tissue.
Figure 7 gives the magnitude spectrum for the fitting of the optimised pseudo-fox off-line model. The tumor has higher APT effect than the normal tissue on the side, and our research finds that the tumor has B effect than the normal tissue1_satHigh NOE signals were present at 1.2 μ T and 2.4 μ T, but at B1_satAt lower power of 0.8 μ T, tumors had lower NOE signals than normal tissue. At the same time, the optimized pseudo-fox-des-line model fit had a higher Glu-CEST and guanidyl-amine pattern in the tumor than in normal tissue. Optimizing the pseudo-Pockey off-line model fit provides a simple robust and also more accurate method to quantify the CEST and NOE effects.

Claims (7)

1. A Z spectrum fitting method based on a pseudo-Poincke off-line type is characterized by comprising the following steps:
step a: acquiring Z spectrum data, and respectively acquiring Z spectrum dataUtilizing a Gaussian function G (delta omega) and a Lorentzian function L (delta omega) to perform pre-fitting to respectively obtain a Gaussian pre-fitting result ZGuassAnd Lorentz pre-fitting results ZLoren
Step b: according to ZGuassAnd ZLorenObtaining a Lorentz proportionality coefficient alpha;
step c: establishing a pseudo-Poinck off-line model of a formula I by using the Lorentz proportionality coefficient alpha obtained in the step b, and fitting Z spectrum data according to the pseudo-Poinck off-line model to obtain a Z spectrum fitting result Zpvp
V (delta omega) ≈ alpha x L (delta omega) + (1-alpha) G (delta omega) formula I
Where V (Δ ω) represents a pseudo-fox offline model.
2. The pseudo-fox-elimination line-based Z spectrum fitting method as recited in claim 1, wherein the step b comprises the substeps of:
step b 1: according to ZGuassAnd ZLorenCalculating the width gamma of the Gaussian half-maximumGAnd half maximum width of lorentz ΓL
Step b 2: calculating the Lorentz proportionality coefficient alpha by adopting a formula II:
Figure FDA0002184283820000011
where Γ represents the half-maximum width of the pseudo-fox trap.
3. A CEST MRI quantification method, comprising:
the method comprises the steps of obtaining a CEST MRI image of an experimental object, obtaining original Z spectrum data of each pixel point in the CEST MRI image, traversing all the pixel points in the image to obtain CEST quantitative values of all the pixel points, and obtaining a CEST quantitative amplitude graph from the CEST quantitative values of all the pixel points, wherein the CEST quantitative value calculation of any pixel point in the CEST MRI image comprises the following steps:
step 1: preprocessing the original Z spectrum data to obtain corrected Z spectrum data Zexp
Step 2: for Z obtained in step 1expUtilizing a Lorentz function to perform pre-fitting to obtain a pre-fitting result ZLoren
And step 3: for Z obtained in step 1expThe positive and negative sides of the Z spectrum are respectively optimized by adopting a formula III and a formula IV to obtain optimized Z spectrum data
Figure FDA0002184283820000022
Wherein the content of the first and second substances,
Figure FDA0002184283820000023
optimized Z spectral data representing positive half spectrum, Ratio (delta omega) representing positive half spectrum compensation factor, LposRepresents ZexpRatio ZLorenA low area between the maximum value of the lower-field frequency offset and the maximum value of the lower-field CEST effect ending frequency offset;
Figure FDA0002184283820000024
wherein the content of the first and second substances,represents the optimized Z spectrum data of the negative half spectrum, Ratio (-delta omega) represents the compensation factor of the negative half spectrum, LnegRepresents ZexpRatio ZLorenA lower area between the maximum value of the upper field frequency offset absolute value and the maximum value of the upper field NOE effect ending frequency offset absolute value;
and 4, step 4: for the product obtained in step 3
Figure FDA0002184283820000026
Blocking, inputting into the pseudo-Pock off-line model of any one of the Z spectrum fitting methods based on the pseudo-Pock off-line type according to claim 1 or 2, and fitting to obtain a fitting signal Zpvp_final
And 5: z obtained according to step 4pvp_finalAnd Z obtained in step 1expAnd obtaining a CEST quantization value.
4. A CEST MRI quantization method as claimed in claim 3, characterized in that Ratio (Δ ω) 0.2318 xb in step 31+0.9502,Ratio(-Δω)=0.4219×B1+0.9131 wherein B1The saturation power used in the experiment to acquire the Z spectrum is shown.
5. A CEST MRI quantification method as claimed in claim 3, characterized in that step 4 comprises the sub-steps of:
step 4.1: will be provided with
Figure FDA0002184283820000031
As a first partition, will
Figure FDA0002184283820000032
As a second partition, will
Figure FDA0002184283820000033
As a third segment;
step 4.2: by blocking the first and second blocks
Figure FDA0002184283820000034
Inputting the signal into a pseudo-Buddk offline model for fitting, fitting the third block by using an LD method, and obtaining a fitting signal Z according to the fitting results of the three blockspvp_final
6. A CEST MRI quantification method according to claim 5, characterized in that in step 4.1 the first fraction is between 0.4ppm and 6ppm, the second fraction is between-6 ppm and-0.4 ppm and the third fraction is between 0.4ppm and-0.4 ppm.
7. A CEST MRI quantization method as claimed in claim 3, characterized in that the CEST quantization value in step 5 comprises three calculation methods:
method (a): calculating Z \uPVP_finalAnd Z_expThe difference of (c) is used as CEST quantization value;
method (b): calculating Z_expReciprocal sum Z ofPVP_finalThe difference of the two inverse numbers of (c) is taken as CEST quantization value;
method (c): calculating Z \uPVP_finalAnd Z_expThe area between the difference and the horizontal axis is taken as the CEST quantization value.
CN201910808222.9A 2019-08-29 2019-08-29 Z spectrum fitting method based on pseudo-Poinck elimination line type and CEST MRI quantification method Active CN110706199B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910808222.9A CN110706199B (en) 2019-08-29 2019-08-29 Z spectrum fitting method based on pseudo-Poinck elimination line type and CEST MRI quantification method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910808222.9A CN110706199B (en) 2019-08-29 2019-08-29 Z spectrum fitting method based on pseudo-Poinck elimination line type and CEST MRI quantification method

Publications (2)

Publication Number Publication Date
CN110706199A true CN110706199A (en) 2020-01-17
CN110706199B CN110706199B (en) 2022-12-27

Family

ID=69193627

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910808222.9A Active CN110706199B (en) 2019-08-29 2019-08-29 Z spectrum fitting method based on pseudo-Poinck elimination line type and CEST MRI quantification method

Country Status (1)

Country Link
CN (1) CN110706199B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112331259A (en) * 2020-11-26 2021-02-05 浙江大学 Tissue metabolite information evaluation method, device and medium based on Bloch-McConnell equation simulation
CN113171076A (en) * 2021-04-29 2021-07-27 浙江大学 CEST data fitting method, device and medium based on extrapolation magnetization transfer signal
CN115349847A (en) * 2022-10-19 2022-11-18 之江实验室 Breast tumor identification system based on separated quantitative APT imaging

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104997511A (en) * 2015-06-01 2015-10-28 中国科学院深圳先进技术研究院 CESTR measuring method and system for magnetic resonance chemical exchange saturation transfer imaging
CN106772165A (en) * 2016-12-30 2017-05-31 深圳先进技术研究院 The determination method and device of amide proton transfer effect
CN107709640A (en) * 2015-07-24 2018-02-16 三菱化学株式会社 The manufacture method of polypropylene fibre and the polypropylene fibre
US20180268546A1 (en) * 2017-03-20 2018-09-20 The General Hospital Corporation Quantification of magnetic resonance data by adaptive fitting of downsampled images

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104997511A (en) * 2015-06-01 2015-10-28 中国科学院深圳先进技术研究院 CESTR measuring method and system for magnetic resonance chemical exchange saturation transfer imaging
CN107709640A (en) * 2015-07-24 2018-02-16 三菱化学株式会社 The manufacture method of polypropylene fibre and the polypropylene fibre
CN106772165A (en) * 2016-12-30 2017-05-31 深圳先进技术研究院 The determination method and device of amide proton transfer effect
US20180268546A1 (en) * 2017-03-20 2018-09-20 The General Hospital Corporation Quantification of magnetic resonance data by adaptive fitting of downsampled images

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
LIHONG ZHANG等: "Voxel-wise Optimization of Pseudo Voigt Profile (VOPVP) for Z-spectra fitting in chemical exchange saturation transfer (CEST) MRI", 《QUANTITATIVE IMAGING IN MEDICINE AND SURGERY》 *
NICOLE D. FICHTNER等: "Elucidation of the downfield spectrum of human brain at 7 T using multiple inversion recovery delays and echo times", 《WILEY ONLINE LIBRARY》 *
T.IDA等: "Extended pseudo-Voigt function for approximating the Voigt profile", 《APPLIED CRYSTALLOGRAPHY》 *
TOMMY S. ALSTRØM等: "A pseudo-Voigt component model for high-resolution recovery of constituent spectra in Raman spectroscopy", 《2017 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP)》 *
张利红: "基于Z谱线型拟合的化学交换饱和转移磁共振成像(CEST-MRI)定量研究", 《中国博士学位论文全文数据库_工程科技Ⅰ辑》 *
杨沙沙: "磁共振氨基质子转移成像在脑胶质瘤中的应用研究", 《中国优秀硕士学位论文全文数据库_医药卫生科技辑》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112331259A (en) * 2020-11-26 2021-02-05 浙江大学 Tissue metabolite information evaluation method, device and medium based on Bloch-McConnell equation simulation
CN112331259B (en) * 2020-11-26 2024-04-12 浙江大学 Tissue metabolite information evaluation method, device and medium based on Bloch-McConnell equation simulation
CN113171076A (en) * 2021-04-29 2021-07-27 浙江大学 CEST data fitting method, device and medium based on extrapolation magnetization transfer signal
CN113171076B (en) * 2021-04-29 2022-01-04 浙江大学 CEST data fitting method, device and medium based on extrapolation magnetization transfer signal
WO2022227639A1 (en) * 2021-04-29 2022-11-03 浙江大学 Cest data fitting method and apparatus based on extrapolated semisolid magnetization transfer reference signal, and medium
CN115349847A (en) * 2022-10-19 2022-11-18 之江实验室 Breast tumor identification system based on separated quantitative APT imaging
CN115349847B (en) * 2022-10-19 2023-01-31 之江实验室 Breast tumor identification system based on separated quantitative APT imaging

Also Published As

Publication number Publication date
CN110706199B (en) 2022-12-27

Similar Documents

Publication Publication Date Title
CN110706199B (en) Z spectrum fitting method based on pseudo-Poinck elimination line type and CEST MRI quantification method
US7277807B2 (en) Method for processing a set of spectra, particularly NMR spectra
Bouhrara et al. Incorporation of Rician noise in the analysis of biexponential transverse relaxation in cartilage using a multiple gradient echo sequence at 3 and 7 Tesla
US20190011516A1 (en) System and method for direct saturation-corrected chemical exchange saturation transfer (disc-cest)
An et al. Simultaneous determination of metabolite concentrations, T1 and T2 relaxation times
Marjańska et al. Altered macromolecular pattern and content in the aging human brain
US9632155B2 (en) Apparatus and method for conductivity and susceptibility reconstruction
Tensaouti et al. Quantitative and reproducibility study of four tractography algorithms used in clinical routine
Deelchand et al. Sensitivity and specificity of human brain glutathione concentrations measured using short‐TE 1H MRS at 7 T
CN110568059B (en) Nondestructive testing method and device for steel wire rope
Sorace et al. Origin and spectroscopic determination of trigonal anisotropy in a heteronuclear single-molecule magnet
Corbin et al. Imperfect spoiling in variable flip angle T1 mapping at 7T: Quantifying and minimizing impact
Afzali et al. Direction‐averaged diffusion‐weighted MRI signal using different axisymmetric B‐tensor encoding schemes
Oakden et al. Effects of diffusion on high‐resolution quantitative T2 MRI
Okada et al. Repeatability of proton magnetic resonance spectroscopy of the brain at 7 T: effect of scan time on semi-localized by adiabatic selective refocusing and short-echo time stimulated echo acquisition mode scans and their comparison
Schmitz‐Abecassis et al. The use of variable delay multipulse chemical exchange saturation transfer for separately assessing different CEST pools in the human brain at 7T
CN105997074A (en) Magnetic resonance quantitative magnetic susceptibility imaging multi-echo phase fitting method
Johnson et al. Three‐Dimensional GRE T1ρ mapping of the brain using tailored variable flip‐angle scheduling
EP2130059B1 (en) Method for determining phase-corrected amplitudes in nmr relaxometric imaging
US8717023B2 (en) Relaxometry quantification self-justification fitting
US20230288513A1 (en) Method for carrying out post-processing on samples of a wasab1 acquisition sequence
Oeltzschner et al. Use of quantitative brain water imaging as concentration reference for J-edited MR spectroscopy of GABA
Feng et al. A novel semiautomatic parenchyma extraction method for improved MRI R2* relaxometry of iron loaded liver
Weis et al. Short echo time MR spectroscopy of brain tumors: grading of cerebral gliomas by correlation analysis of normalized spectral amplitudes
WO2014165719A1 (en) Non-invasive imaging of tissue redox state by mri

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant